{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:35:41Z","timestamp":1780349741929,"version":"3.54.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Vacuoles, E1 syndrome, X-linked, autoinflammatory, somatic (VEXAS) syndrome is a chronic inflammatory disorder that affects various organ systems. It is associated with hematologic malignancies and is generally refractory to therapies. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be considered for selected patients. We report a case wherein systemic and hematological manifestations completely resolved in a patient with VEXAS and associated myelodysplastic syndrome (MDS), following the administration of fludarabine and cyclophosphamide as part of the preparation for allo-HSCT. We conducted a systematic literature review and included 86 patients with VEXAS syndrome and associated MDS. Most cases presented with musculoskeletal involvement (71%) and anemia (72%) with lower-risk MDS. Most patients responded to corticosteroids (CS) but had a recurrence of symptoms with CS taper and were refractory to other immunosuppressive agents. Hypomethylating agents and Janus kinase inhibitors achieved a complete response in some cases. Further research is needed to develop more effective treatment strategies.<\/jats:p>","DOI":"10.3389\/fonc.2024.1383730","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T04:44:36Z","timestamp":1712810676000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"Polina","family":"Bellman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus D.","family":"Gonzalez-Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moazzam","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Kashif","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Fareed","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausheen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulraheem","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"McGuirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Umair","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.24836","article-title":"Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population","volume":"329","author":"Beck DB","year":"2023","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010811","article-title":"Vacuolization of hematopoietic precursors: an enigma with multiple etiologies","volume":"137","author":"Gurnari","year":"2021","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011455","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and Malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071590","article-title":"VEXAS syndrome: A novelty in MDS landscape","volume":"12","author":"Temple","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.897722","article-title":"Case report: coexistence of multiple myeloma and auricular chondritis in VEXAS syndrome","volume":"13","author":"Matsumoto","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40164-021-00217-2","article-title":"VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder","volume":"10","author":"Huang","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.14540","article-title":"VEXAS syndrome with severe multisystem involvement: Rapid recovery after splenectomy","volume":"26","author":"Yildirim","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010286","article-title":"Novel somatic mutations in UBA1 as a cause of VEXAS syndrome","volume":"137","author":"Poulter","year":"2021","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010177","article-title":"Therapeutic options in VEXAS syndrome: insights from a retrospective series","volume":"137","author":"Bourbon","year":"2021","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002255","article-title":"Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients","volume":"8","author":"Khitri","year":"2022","journal-title":"RMD Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMc2102124","article-title":"Mutant UBA1 and severe adult-onset autoinflammatory disease","volume":"384","author":"Arlet","year":"2021","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280238","article-title":"VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)","volume":"107","author":"Stubbins","year":"2022","journal-title":"Haematologica"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2102124","article-title":"Mutant UBA1 and severe adult-onset autoinflammatory disease","volume":"384","author":"Beck","year":"2021","journal-title":"Reply N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1056\/NEJMc2102124","article-title":"Mutant UBA1 and severe adult-onset autoinflammatory disease","volume":"384","author":"Luzzatto","year":"2021","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2021.10.007","article-title":"Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome","volume":"58","author":"Patel","year":"2021","journal-title":"Semin Hematol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/hs9.0000000000000661","article-title":"Azacytidine treatment for VEXAS syndrome","volume":"5","author":"Raaijmakers","year":"2021","journal-title":"Hemasphere"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s44228-022-00002-w","article-title":"Clinical, morphological and clonal progression of VEXAS syndrome in the context of myelodysplasia treated with azacytidine","volume":"4","author":"Manzoni","year":"2022","journal-title":"Clin Hematol Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016985","article-title":"Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis","volume":"140","author":"Ferrada","year":"2022","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17893","article-title":"Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry","volume":"196","author":"Comont","year":"2022","journal-title":"Br J Haematol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1182\/bloodadvances.2021004749","article-title":"Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience","volume":"6","author":"Diarra","year":"2022","journal-title":"Blood Adv"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-023-03532-y","article-title":"Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome","volume":"117","author":"Kataoka","year":"2023","journal-title":"Int J Hematol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235586","article-title":"USAID associated with myeloid neoplasm and VEXAS syndrome: two differential diagnoses of suspected adult onset still's disease in elderly patients","volume":"10","author":"Delplanque","year":"2021","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab866","article-title":"Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis","volume":"61","author":"Cordts","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-251089","article-title":"VEXAS syndrome with progression of MDS to MDS\/MPN overlap syndrome","volume":"15","author":"Neupane","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab349","article-title":"A Case of polychondritis-onset refractory organizing pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of 7 years","volume":"60","author":"Sakuma","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.901063","article-title":"Case report: tocilizumab treatment for VEXAS syndrome with relapsing polychondritis: A single-center, 1-year longitudinal observational study in Japan","volume":"13","author":"Kunishita","year":"2022","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS","volume":"149","author":"van der Made","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.210149","article-title":"Somatic mutation in UBA1 and ANCA-associated vasculitis","volume":"48","author":"Ross","year":"2021","journal-title":"J Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.800149","article-title":"Case report: genetic double strike: VEXAS and TET2-positive myelodysplastic syndrome in a patient with long-standing refractory autoinflammatory disease","volume":"12","author":"L\u00f6tscher","year":"2021","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01544-y","article-title":"Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report","volume":"57","author":"Loschi","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01676830.2022.2126501","article-title":"Recurrent orbital inflammation associated with VEXAS syndrome","volume":"2022","author":"Beecher","year":"2022","journal-title":"Orbit"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1177\/15353702231165030","article-title":"JAK inhibitors for the treatment of VEXAS syndrome","volume":"248","author":"Bindoli","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.41992","article-title":"VEXAS syndrome: A case series from a single-center cohort of italian patients with vasculitis","volume":"74","author":"Muratore","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15742","article-title":"VEXAS syndrome: lessons learnt from an early Australian case series","volume":"52","author":"Islam","year":"2022","journal-title":"Intern Med J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39906","article-title":"A case of VEXAS: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome with co-existing DNA (Cytosine-5)-methyltransferase 3A mutation complicated by localized skin reaction to tocilizumab and azacitidine","volume":"15","author":"Estes","year":"2023","journal-title":"Cureus"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06338-1","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review","volume":"41","author":"Guerrero-Berm\u00fadez","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01070-y","article-title":"A case of VEXAS syndrome complicated by hemophagocytic lymphohistiocytosis","volume":"41","author":"Grey","year":"2021","journal-title":"J Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01353-8","article-title":"Prevalence of UBA1 mutations in MDS\/CMML patients with systemic inflammatory and auto-immune disease","volume":"35","author":"Zhao","year":"2021","journal-title":"Leukemia"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/art.42471","article-title":"Novel somatic UBA1 variant in a patient with VEXAS syndrome","volume":"75","author":"Stiburkova","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/mrcr\/rxac082","article-title":"Acute heart failure due to left common iliac arteriovenous fistula: A case of VEXAS syndrome","volume":"7","author":"Yamaguchi","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.06.006","article-title":"Clinical heterogeneity of the VEXAS syndrome: A case series","volume":"96","author":"Koster","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18488","article-title":"Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience","volume":"199","author":"Al-Hakim","year":"2022","journal-title":"Br J Haematol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1002\/ajh.26786","article-title":"Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients","volume":"98","author":"Mangaonkar","year":"2023","journal-title":"Am J Hematol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01698-8","article-title":"A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune\/inflammatory disorders and VEXAS syndrome associated with MDS and CMML","volume":"36","author":"Mekinian","year":"2022","journal-title":"Leukemia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab211","article-title":"VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy","volume":"60","author":"Magnol","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12185-023-03598-8","article-title":"Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome","volume":"118","author":"Kunimoto","year":"2023","journal-title":"Int J Hematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2016.02.005","article-title":"Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"43","author":"Fraison","year":"2016","journal-title":"Leuk Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1383730\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T04:44:39Z","timestamp":1712810679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1383730\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":50,"alternative-id":["10.3389\/fonc.2024.1383730"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1383730","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]},"article-number":"1383730"}}